Eyepoint Pharms Drug Patent Portfolio

Eyepoint Pharms owns 1 orange book drug protected by 7 US patents Given below is the list of Eyepoint Pharms's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11097061 Systems, kits and methods for loading and delivering a small volume dose from a syringe 23 Jun, 2039
Active
US10022502 Dose guides for injection syringe 22 Jun, 2034
Active
US10028965 Use of sustained release dexamethasone in post-cataract surgery inflammation 23 May, 2034
Active
US10159683 Use of sustained release dexamethasone in post-cataract surgery inflammation 23 May, 2034
Active
US10799642 Dose guides for injection syringe 11 May, 2032
Active
US6960346 Vehicles for delivery of biologically active substances 03 Jul, 2023 Expired
US7560120 Vehicles for delivery of biologically active substances 05 Sep, 2022 Expired


Given below is the list of recent legal activities going on the following drug patents of Eyepoint Pharms.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 27 Mar, 2024 US10799642
Payment of Maintenance Fee, 4th Yr, Small Entity 08 Jun, 2022 US10159683
Payment of Maintenance Fee, 4th Yr, Small Entity 12 Jan, 2022 US10028965
Payment of Maintenance Fee, 4th Yr, Small Entity 05 Jan, 2022 US10022502
Patent Issue Date Used in PTA Calculation 24 Aug, 2021 US11097061
Recordation of Patent Grant Mailed 24 Aug, 2021 US11097061
Email Notification 05 Aug, 2021 US11097061
Issue Notification Mailed 04 Aug, 2021 US11097061
Application Is Considered Ready for Issue 22 Jul, 2021 US11097061
Dispatch to FDC 22 Jul, 2021 US11097061
Issue Fee Payment Received 21 Jul, 2021 US11097061
Issue Fee Payment Verified 21 Jul, 2021 US11097061
Electronic Review 23 Apr, 2021 US11097061
Email Notification 23 Apr, 2021 US11097061
Mail Notice of Allowance 23 Apr, 2021 US11097061


Eyepoint Pharms's Family Patents

Eyepoint Pharms drugs have patent protection in a total of 20 countries. It's US patent count contributes only to 37.5% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Eyepoint Pharms Drug List

Given below is the complete list of Eyepoint Pharms's drugs and the patents protecting them.


1. Dexycu Kit

Dexycu Kit is protected by 7 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11097061 Systems, kits and methods for loading and delivering a small volume dose from a syringe 23 Jun, 2039
(14 years from now)
Active
US10022502 Dose guides for injection syringe 22 Jun, 2034
(9 years from now)
Active
US10028965 Use of sustained release dexamethasone in post-cataract surgery inflammation 23 May, 2034
(9 years from now)
Active
US10159683 Use of sustained release dexamethasone in post-cataract surgery inflammation 23 May, 2034
(9 years from now)
Active
US10799642 Dose guides for injection syringe 11 May, 2032
(7 years from now)
Active
US6960346 Vehicles for delivery of biologically active substances 03 Jul, 2023
(1 year, 3 months ago)
Expired
US7560120 Vehicles for delivery of biologically active substances 05 Sep, 2022
(2 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Dexycu Kit's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List